Ekso Bionics (EKSO) Reports In-Line Q2 EPS

Ekso Bionics (NASDAQ: EKSO) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.15 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• PreveCeutical closes second tranche of private placement for $245,000
• Independence Realty Trust (IRT) files mixed shelf